School of Medicine


Showing 11-20 of 45 Results

  • David Feldman

    David Feldman

    Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus

    Current Research and Scholarly InterestsStudies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.

  • Dean W. Felsher

    Dean W. Felsher

    Professor of Medicine (Oncology) and of Pathology

    Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

  • Jessica Ferguson

    Jessica Ferguson

    Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.

  • Nielsen Fernandez-Becker

    Nielsen Fernandez-Becker

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
    My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients.

  • George A. Fisher Jr.

    George A. Fisher Jr.

    Colleen Haas Chair in the School of Medicine

    Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.

  • Peter Fitzgerald, MD, PhD

    Peter Fitzgerald, MD, PhD

    Professor (Research) of Medicine (Cardiovascular), Emeritus

    BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program.
    Dr. Fitzgerald has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. He has transitioned fourteen of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures, which is an incubator/venture fund for early stage medical technology in Israel.

  • Aubrey L. Florom-Smith, PhD, RN, AFAsMA

    Aubrey L. Florom-Smith, PhD, RN, AFAsMA

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioAubrey Florom-Smith, PhD, RN, AFAsMA, is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health, at the Stanford University School of Medicine. She is a Nurse Scientist and Manager of Patient Care Research in the Office of Research, Patient Care Services at Stanford Health Care, where she supports nursing and interprofessional research. Dr. Florom-Smith has over 10 years of nursing, clinical, and applied research experience, across a wide range of areas of inquiry, and in healthcare, corporate, and laboratory settings. She obtained her Bachelor of Science in Nursing and her PhD in Nursing Science from the University of Miami, where she was the first National Institutes of Health/National Institute of Nursing Research Predoctoral Fellow at the School of Nursing and Health Studies. Dr. Florom-Smith’s research interests include understanding, sustaining and enhancing human health and performance during spaceflight, adapting impactful countermeasures and interventions for use at the terrestrial bedside and in space, and advancing space nursing as a nursing specialization. Inducted into Sigma Theta Tau in 2008, Dr. Florom-Smith has received several honors and awards, including the 2020 University of Miami Alumnus of Distinction Award, the Aerospace Nursing and Allied Health Professionals Society Louise Marshall Nursing Scholarship, the Jonas Foundation Nurse Leader Scholar, the Sigma Theta Rising Star of Scholarship and Research Award, and the March of Dimes Rising Star Award. Dr. Florom-Smith is an Associate Fellow of the Aerospace Medical Association.